Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.

Quotes for Redwood Pharma AB

Right Now

+/-
0.05
%
0,46%
Latest
11
High
11.5
Low
10.85
Volume
16 941
Turnover (SEK)
185 195
Value (MSEK)
164,9

Board

CEO

  • Martin Vidaeus

Chairman Of The Board

  • Gunnar Mattsson

Board

  • Hans Ageland
  • Ingrid Atteryd-Heiman
  • Martin Vidaeus
  • Mats Lidgard

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 9,35 9,35 2020-03-31
Martin Vidaeus 8,11 8,11 2020-03-31
Jan Petersen 3,90 3,90 2020-03-31
Capa Vision Ltd 2,85 2,85 2019-06-28
Hans Gunnar Ageland 2,80 2,80 2019-09-30
Joel Henriksson 2,04 2,04 2020-03-31
Nordnet Pensionsförsäkring 1,15 1,15 2020-03-31
Fabian Karlsson 1,06 1,06 2020-03-31
Anders Joachim Welin 0,79 0,79 2020-03-31
Patrik Antonsson 0,72 0,72 2020-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-08-28 Delårsrapport 2020-Q2

  • 2020-11-17 Delårsrapport 2020-Q3